It tests invasive breast cancer, 0.6 cm or larger for hormonal positive, to determine if chemotherapy would be beneficial to prevent recurrence.
May 2, 2025 (edited)
The Oncotype DX test is a genetic analysis tool that helps doctors predict two important things about breast cancer: how likely the cancer is to return (recur) and whether the cancer will respond well to treatment.
This test provides crucial information that helps oncologists determine the most effective treatment plan for Show Full Answer
The Oncotype DX test is a genetic analysis tool that helps doctors predict two important things about breast cancer: how likely the cancer is to return (recur) and whether the cancer will respond well to treatment.
This test provides crucial information that helps oncologists determine the most effective treatment plan for each individual patient. The results help guide decisions about whether chemotherapy would be beneficial in addition to hormone therapy. The test analyzes specific genes in breast cancer tissue to generate a "recurrence score" - a number that helps predict the likelihood that the cancer will come back. This information is particularly valuable because it helps doctors and patients make more informed decisions about treatment options, potentially avoiding unnecessary treatments while ensuring adequate care is provided based on the individual's specific cancer profile.
May 1, 2025
Join
Your Privacy Choices
